Faculty of Biology, Medicine and Health

The University of Manchester

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities

  (MBRC) Widening uptake and adherence to treatment with hearing aids via a new model of service delivery

Prof K Munro, Dr Michael Stone, Prof Harvey Dillon, Dr D Moore  No more applications being accepted  Funded PhD Project (European/UK Students Only)

About the Project

The average age of first-time wearers of hearing aids dispensed by the NHS is 74 years, by which time candidates typically have a moderate hearing loss and are struggling in many listening situations. Corrected sensory losses reduce handicap, improve quality of life, reduce the number of years lived with a disability and are associated with better physical health (Dawes et al., 2015). Earlier adoption of aiding, when the hearing loss is milder in degree, has the potential to produce better outcomes.
“Over-the-counter” devices (OTCs) are simpler, more affordable hearing aids available without a prescription. They may promote earlier adoption by being more accessible and reducing the stigma often associated with conventional hearing aids (cHAs). Here, we distinguish OTCs from other types of “personal sound amplification products” (PSAPs), multi-function, in-the-ear devices (“hearables”), and software implemented on a smartphone. These latter devices amplify sound but do not compensate for hearing loss, and/or are not conveniently wearable on the head. Although OTCs are much cheaper to acquire than cHAs, some amplify sound in much the same manner, so there is the potential for them to work as well, and limited research partially supports this claim (Humes et al., 2017). Nevertheless, questions remain as to their technical efficacy and suitability (Chan & McPherson, 2015), acceptability, and success rates as measured by adherence and other outcome measures. Interest in OTCs has also been driven by pressure to reduce costs from health service commissioners by limiting the provision of conventional hearing aids and reducing contact with medical professionals. Self-funding and self-fitting of simpler devices (Humes et al., 2017), such as OTCs, may therefore become the delivery method for at least some patients as an interim intervention before a hearing loss becomes more severe.

This PhD will explore factors that determine the acceptability of OTCs compared to hearing aids. These factors are likely to be multiple and complex and may include cosmetic, functional, client-oriented (age, personality, health literacy, familiarity with technology), and service delivery (professional support) issues.

Funding Notes

Applicants must have obtained, or be about to obtain, at least an upper second class honours degree (or equivalent) in a relevant subject.

Applicants must be from the UK/EU and funding covers fees/stipend for three years commencing January 2019 or April 2019. Applicants may contact the Primary Supervisor directly with any questions. Online applications must be submitted, select 'Manchester BRC' as the programme - for more information on how to apply please visit https://www.bmh.manchester.ac.uk/study/research/funded-programmes/mbrc-studentships/

References

1. Chan ZYT & McPherson, B (2015) Over-the-counter hearing aids: a lost decade for change. Biomed Research International, Article ID 827463.
2. Dawes P, Cruickshanks KJ, Fischer ME, Klein EK, Klein R (2015) Hearing-aid use and long-term health outcomes: Hearing handicap, mental health, social engagement, cognitive function, physical health, and mortality. Int J Audiol 54:838–844
3. Humes LE, Rogers SE, QuigleyTM, Main AK, Kinney DL, Herring C (2017). The Effects of Service-Delivery Model and Purchase Price on Hearing-Aid Outcomes in Older Adults: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Amer J Audiol 26:53-79.
4. Manchaiah V, Taylor B, Dockens AL, Tran NR, Lane K, Castle M, Grover V (2017). Applications of direct-to-consumer hearing devices for adults with hearing loss: a review. Clin Interv Aging 12:859-871.
5. MacPherson A, Akeroyd MA (2014). A method for measuring the intelligibility of uninterrupted, continuous speech. JASA 135:1027-1030.


Where will I study?

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at the Faculty of Biology, Medicine and Health?

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It's not just a place to research, it's a place to call home.

With 93% of research activity at the University rated as 'world-leading' or 'internationally excellent' (Research Excellence Framework, 2021), you'll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

6th

in the UK - QS (2025)

Manchester  United Kingdom

main campus

About the Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.


Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully